Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Chemocentryx Inc (NQ: CCXI ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Oct 19, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Chemocentryx Inc < Previous 1 2 3 4 5 6 7 8 9 Next > The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of ChemoCentryx, Inc. (CCXI) Investors May 07, 2021 From The Law Offices of Frank R. Cruz Via Business Wire SHAREHOLDER ALERT: Robbins LLP Announces That ChemoCentryx, Inc. (CCXI) is Being Sued for Misleading Shareholders May 07, 2021 From Robbins LLP Via Business Wire Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline for Securities Fraud Class Action Lawsuit Filed Against ChemoCentryx, Inc. May 07, 2021 From Kessler Topaz Meltzer & Check, LLP Via Business Wire Mid-Afternoon Market Update: Dow Surges Over 200 Points; ChemoCentryx Shares Drop May 07, 2021 Toward the end of trading Friday, the Dow traded up 0.62% to 34,761.24 while the NASDAQ rose 0.95% to 13,762.12. The S&P also rose, gaining 0.74% to 4,232.81. The U.S. has the... Via Benzinga Topics Stocks Exposures US Equities Stocks Reverse Course, Investors Look at Flip Side of Economic Data May 07, 2021 While a lackluster April jobs report initially sunk stocks this morning, the indexes are bouncing back as investors speculate that the disappointing data could mean the continuation of easy policies... Via Talk Markets Topics Economy Exposures Interest Rates 12 Health Care Stocks Moving In Friday's Intraday Session May 07, 2021 Gainers Yield10 Bioscience (NASDAQ:YTEN) stock increased by 20.74% to $10.36 during Friday's regular session. As of 12:30 EST, Yield10 Bioscience's stock is... Via Benzinga Why ChemoCentryx Stock Is Cratering Again Today May 07, 2021 Investors aren't optimistic after an FDA advisory committee vote for avacopan. Via The Motley Fool Exposures Product Safety Mid-Day Market Update: Pro-Dex Rises After Q3 Results; Orphazyme Shares Slide May 07, 2021 Midway through trading Friday, the Dow traded up 0.45% to 34,705.48 while the NASDAQ rose 1.35% to 13,816.46. The S&P also rose, gaining 0.77% to 4,233.93. The U.S. has the... Via Benzinga Topics Stocks Exposures US Equities SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ChemoCentryx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm May 07, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal Why ChemoCentryx Shares Are Plunging Today May 07, 2021 ChemoCentryx (NASDAQ: CCXI) shares are trading lower following a vote from the FDA panel on whether the efficacy data support approval on its Avacopan in ANCA-Associated... Via Benzinga Exposures Product Safety Mid-Morning Market Update: Markets Open Higher; US Adds Only 266,000 Jobs In April May 07, 2021 Following the market opening Friday, the Dow traded up 0.40% to 34,686.06 while the NASDAQ rose 1.16% to 13,790.95. The S&P also rose, gaining 0.69% to 4,230.68. The U.S. has... Via Benzinga Topics Stocks Exposures US Equities 56 Stocks Moving In Friday's Mid-Day Session May 07, 2021 Gainers InnSuites Hospitality Trust (NYSE: IHT) shares jumped 77% to $4.321. Regional Health Properties, Inc. (NYSE: RHE) gained 43% to $21.40 after dropping 23% on Thursday.... Via Benzinga Analysts React To FDA AdCom Vote On ChemoCentryx's Avacopan, Stock Plunges May 07, 2021 Yesterday, the FDA’s Arthritis Advisory Committee panelists went through cloudy data while complaining about the design of the Phase 3 trial for ChemoCentryx Inc... Via Benzinga Exposures Product Safety Benzinga's Top Ratings Upgrades, Downgrades For May 7, 2021 May 07, 2021 Upgrades Loop Capital upgraded the previous rating for Roku Inc (NASDAQ:ROKU) from Hold to Buy. In the first quarter, Roku showed an EPS of $0.54, compared to $0.45 from... Via Benzinga ChemoCentryx Stock Loses Half Its Value; Is This The Final Nail For Its Drug? May 07, 2021 A panel of experts was split Thursday on whether to recommend approval for ChemoCentryx's autoimmune disease drug — and CCXI stock plummeted Friday. Via Investor's Business Daily 10 Biggest Price Target Changes For Friday May 07, 2021 Stifel boosted Wayfair Inc. (NYSE: W) price target from $200 to $280. Wayfair shares rose 1.7% to $290.91 in pre-market trading. RBC Capital raised ViacomCBS Inc. (NASDAQ: VIAC... Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session May 07, 2021 Gainers Assertio Holdings (NASDAQ:ASRT) shares moved upwards by 32.42% to $0.66 during Friday's pre-market session. The company's market cap stands at $114.5... Via Benzinga Adcomm Split On FDA Approval For ChemoCentryx's Vasculitis Candidate May 07, 2021 The FDA’s Arthritis Advisory Committee voted 10 for and 8 against the approval of ChemoCentryx Inc’s (NASDAQ: CCXI) investigational drug... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs May 07, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:... Via Benzinga CHEMOCENTRYX SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against ChemoCentryx, Inc. - CCXI May 06, 2021 From Kahn Swick & Foti, LLC Via Business Wire Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of ChemoCentryx, Inc. (CCXI) on Behalf of Investors May 06, 2021 From Glancy Prongay & Murray LLP Via Business Wire SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ChemoCentryx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm May 06, 2021 From The Schall Law Firm Via Business Wire The Law Offices of Frank R. Cruz Announces Investigation of ChemoCentryx, Inc. (CCXI) on Behalf of Investors May 06, 2021 From The Law Offices of Frank R. Cruz Via Business Wire INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of ChemoCentryx, Inc. (CCXI) on Behalf of Investors May 06, 2021 From Law Offices of Howard G. Smith Via Business Wire ChemoCentryx Investors With Losses Greater Than $100,000 - Kehoe Law Firm, P.C. Securities Class Action Investigation May 06, 2021 Class Action Investigation On Behalf Of ChemoCentryx Investors With Significant Losses Via EIN Presswire Topics Fraud Lawsuit Exposures Financial Legal ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against ChemoCentryx, Inc. and Encourages Investors with Losses to Contact the Firm May 06, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal Product Safety DEADLINE ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against ChemoCentryx, Inc. and Encourages Investors to Contact the Firm May 06, 2021 From Bragar Eagel & Squire, P.C. Via Business Wire EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages ChemoCentryx, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline – CCXI May 06, 2021 From The Rosen Law Firm, P.A. Via Business Wire INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against ChemoCentryx, Inc. and Encourages Investors with Losses to Contact the Firm May 05, 2021 From The Schall Law Firm Via Business Wire The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom May 06, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)... Via Benzinga Exposures Product Safety < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
